The "Buzz" Might Be Gone (And Thats a Good Thing!) One of the most surprising side effects patients report is that they simply dont want to drink as much as they used to
Results at 36 weeks by dose group: The critical finding: the proportion of lean mass loss to total weight loss was comparable to other obesity medications
Please also read through the articles on type 2 diabetes genes
Journal of Alternative Complementary Medicine
Several large clinical studies, the majority of which are cardiovascular outcome trials, indicate that GLP-1 RA therapy is safe and tolerable for people living with T2DM and compromised renal function, and also suggest that GLP-1 RAs may have renoprotective properties
The age-related differences in neurological complications observed in COVID-19 patients thus highlight the impact of mitochondrial dysfunction, as evidenced by the increased prevalence of cerebrovascular disease and encephalopathy in older adults, as shown in Table 2